Med Page Today
APRIL 8, 2024
(MedPage Today) -- ATLANTA -- The concept of using stents to seal off non-flow-limiting vulnerable plaques, before they have a chance to rupture, worked out in the first major trial testing this provocative idea. Compared with standard medical.
Becker's Hospital Review - Cardiology
APRIL 8, 2024
The FDA convened a committee of advisers to assess a cardiac device made by Abbott, but the agency did not disclose that 10 of the 14 members had received payments from the company or conducted research it had funded, KFF Health News reported April 8.
Med Page Today
APRIL 8, 2024
(MedPage Today) -- ATLANTA -- The vast majority of people correctly identified their own need for a statin using a web tool and took the drug appropriately without a prescription, according to an actual use study, supporting the safety of approval.
DAIC
APRIL 8, 2024
milla1cf Mon, 04/08/2024 - 17:57 April 8, 2024 — People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin alongside the P2Y12 inhibitor ticagrelor one month after undergoing percutaneous coronary intervention (PCI) saw a significantly reduced risk of clinically meaningful bleeding with no increased risk of clotting-related adverse events at 12 months compared with patients who continued taking aspirin and ticagrelor for a full year, in a study prese
Science Daily - Heart Disease
APRIL 8, 2024
Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily, new study suggests.
DAIC
APRIL 8, 2024
milla1cf Mon, 04/08/2024 - 18:27 April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to increased risk of heart disease and stroke out of the body, according to a study presented at the American College of Cardiology ’s Annual Scientific Session.
Science Daily - Heart Disease
APRIL 8, 2024
Coronary artery disease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers have found.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Science Daily - Heart Disease
APRIL 8, 2024
For heart attack patients, treating only the coronary artery that caused the infarction works just as well as preventive balloon dilation of the other coronary arteries, according to a new large study.
Medical Xpress - ECG
APRIL 8, 2024
An electronic sock that detects an unhealthy walking style linked with diabetes and poor circulation shows promise for preventing foot ulcers and amputation. The novel research is set to benefit the many patients with diabetes who have clogged arteries in the legs and is presented for the first time at EHRA 2024.
HCPLive
APRIL 8, 2024
The study highlights how the experience of loneliness for care partners of people with dementia changes relationship roles throughout the dementia trajectory.
Science Daily - Heart Disease
APRIL 8, 2024
Researchers unveiled BeatProfiler, a groundbreaking new tool -- a comprehensive software that automates the analysis of heart cell function from video data. It's the first system to integrate the analysis of different heart function indicators, such as contractility, calcium handling, and force output into one tool, speeding up the process significantly and reducing the chance for errors.
Med Page Today
APRIL 8, 2024
(MedPage Today) -- ATLANTA -- Beta-blockers had no additive benefit over contemporary therapies for people with acute myocardial infarction (MI) maintaining a preserved left ventricular ejection fraction (LVEF), the REDUCE-AMI randomized trial.
HCPLive
APRIL 8, 2024
Oral iron supplements did not significantly differ in increasing hemoglobin and ferritin levels, but the every-other-day oral iron proved more effective than daily use.
Med Page Today
APRIL 8, 2024
(MedPage Today) -- ATLANTA -- Chelation to remove lead and other heavy metals didn't improve outcomes for type 2 diabetes patients after myocardial infarction (MI), the TACT2 trial showed. Cumulative incidence of time to first event (MI, stroke.
American College of Cardiology
APRIL 8, 2024
The goal of the PREVENT trial was to compare the safety and efficacy of medical therapy along with focal preventive PCI of non-flow-limiting vulnerable plaque compared with medical therapy alone.
Med Page Today
APRIL 8, 2024
(MedPage Today) -- ATLANTA -- For transcatheter aortic valve replacement (TAVR) candidates with a small aortic annulus, the two leading platforms offered differing hemodynamic valve performances despite being similarly effective at 1 year, according.
HeartRhythm
APRIL 8, 2024
There is insufficient data assessing the regional differences in catheter ablation outcomes for atrial fibrillation (AF) in the United States. We examined such variations by analyzing procedural complications and in-hospital outcomes among patients undergoing AF ablation utilizing the National Inpatient Sample (NIS), a collaborative effort between federal, state, and industry stakeholders sponsored by the Agency for Healthcare Research and Quality (AHRQ), captures hospital data from over 7 milli
American College of Cardiology
APRIL 8, 2024
PCI performed preventively in patients with high-risk vulnerable plaques was found to be superior to optimal medical therapy alone in preventing a serious cardiac event, according to the results of the PREVENT trial, the largest study on preventive PCI to date, presented during a Late-Breaking Clinical Trial session during ACC.24 in Atlanta and published simultaneously in The Lancet.
Science Daily - Heart Disease
APRIL 8, 2024
Trial findings suggest that the less invasive approach to heart bypass surgery offers comparable safety and efficacy to established methods and that safety issues inherent to invasive catheterisation investigation can be replaced by a non-invasive technique using CT scan imaging and AI-powered blood flow analysis.
HCPLive
APRIL 8, 2024
Martin Maron, MD, discusses the results of the IMPROVE-HCM trial and how it informs the community on the potential of plozasiran.
American College of Cardiology
APRIL 8, 2024
Drs. Wilson, Fry, and Kramer; Past Presidents of the College; Trustees; Governors; Partner Society Leaders; Distinguished Guests, Awardees; friends and family; tonight, I am deeply humbled and privileged to stand before you as President of the American College of Cardiology.
HCPLive
APRIL 8, 2024
These nationwide data contribute to the overall body of research on extraintestinal inflammatory conditions among MC patients, highlighting the value of studying the mechanisms involved.
American College of Cardiology
APRIL 8, 2024
The goal of the IVUS-DCB trial was to evaluate intravascular ultrasound (IVUS)-guided drug-coated balloon angioplasty compared with angiography-guided drug-coated balloon angioplasty among patients with femoropopliteal artery disease.
HCPLive
APRIL 8, 2024
Talal highlights the use of facilitated telemedicine for increasing access to HCV treatment and other areas it might expand access for underserved patient populations.
American College of Cardiology
APRIL 8, 2024
"Who I am NOT has captured a lot of people's attention. So, who am I? I am Cathie Biga, a leader, health care administrator, nurse, executive, mom, wife, nana and I still think of myself as a 'recovering' critical care nurse.
Science Daily - Heart Disease
APRIL 8, 2024
New research could change standard-of-care guidelines to improve outcomes for heart attack patients after coronary stenting procedures.
HCPLive
APRIL 8, 2024
In these data, investigators had investigated the international differences in topical AK medication implementation, including links to countries’ different economic statuses.
Med Page Today
APRIL 8, 2024
(MedPage Today) -- ATLANTA -- A novel antisense mRNA drug slashed triglycerides in higher risk or moderate hypertriglyceridemia patients and in those with extremely elevated levels from familial chylomicronemia syndrome, two randomized phase.
American College of Cardiology
APRIL 8, 2024
Patients who took the ACE inhibitor enalapril while undergoing cancer treatment with high-dose anthracycline chemotherapy did not show any difference in troponin T levels at one month after their last chemotherapy dose compared with those who did not take it, according to results from the PROACT study presented during a Late-Breaking Clinical Trial session at ACC.24 in Atlanta.
HCPLive
APRIL 8, 2024
EMERGENT-3 trial showed xanomeline-trospium was effective in improving schizophrenia symptoms at 52 weeks, for participants who took either placebo or KarXT in acute trials.
Science Daily - Heart Disease
APRIL 8, 2024
New technology uses a smartphone to analyze heart movement and detect heart failure.
American College of Cardiology
APRIL 8, 2024
Last year, we fully embraced the end to the COVID Pandemic. This year – and by this year I mean today – we are experiencing a total eclipse of the sun! Next year we will try and find something equally dramatic to celebrate.
HCPLive
APRIL 8, 2024
Obesity was linked to a lower likelihood of obtaining response to treatment during the 48-week follow-up period.
American College of Cardiology
APRIL 8, 2024
Today's Convocation ceremony beginning at 4 p.m. ET will close out ACC.24 by celebrating the College's 75-year history, applauding the many accomplishments of ACC members around the world, welcoming new Fellows and Associates to the ACC family, and recognizing Cathleen Biga, MSN, FACC, as the College's next president.
Journal of Cardiothoracic Surgery
APRIL 8, 2024
Background Primary cardiac angiosarcoma(PCA) has a low incidence rate and poor prognosis. Currently, no unified clinical treatment standards are available. Case presentation We report the case of a 48-year-old man presenting chest tightness, breathlessness, and dyspnea. Imaging and postoperative histopathologic studies confirmed PCA and that the tumor had invaded the entire right atrium.
American College of Cardiology
APRIL 8, 2024
The goal of the DEDICATE-DZHK6 trial was to evaluate transcatheter aortic valve implantation (TAVI) compared with surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis and low to intermediate surgical risk.
Journal of Cardiothoracic Surgery
APRIL 8, 2024
Perioperative bleeding poses a significant issue during thoracic surgery. Tranexamic acid (TXA) is one of the most commonly used antifibrinolytic agents for surgical patients. The purpose of the current study.
Expert insights. Personalized for you.
119 
Let's personalize your content